SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001683168-24-004772
Filing Date
2024-07-12
Accepted
2024-07-11 19:38:57
Documents
13
Period of Report
2024-07-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A cns_8ka.htm   iXBRL 8-K/A 30606
  Complete submission text file 0001683168-24-004772.txt   207626

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cnsp-20240705.xsd EX-101.SCH 3018
3 XBRL LABEL FILE cnsp-20240705_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cnsp-20240705_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT cns_8ka_htm.xml XML 3920
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39126 | Film No.: 241112975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)